Single-Cell Omics Market: Industry Analysis, Size, Share, Growth And Forecast To 2033

The new report published by The Business Research Company, titled Single-Cell Omics Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033, delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.

As per the report, the single-cell omics market size has grown rapidly in recent years. It will grow from $1.81 billion in 2023 to $2.1 billion in 2024 at a compound annual growth rate (CAGR) of 16.3%. The single-cell omics market size is expected to see rapid growth in the next few years. It will grow to $3.84 billion in 2028 at a compound annual growth rate (CAGR) of 16.2%.

Download Free Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=12379&type=smp

Rising Cancer Prevalence Propels Growth In The Single-Cell Omics Market
The rising prevalence of cancer is expected to propel the growth of the single-cell omics market going forward. Cancer is a category of illnesses that can develop in nearly any organ or tissue in the body when aberrant cells proliferate uncontrollably, cross their usual boundaries, and either spread to other organs or invade neighboring body parts. Identifying biomarkers for cancer diagnosis, prognosis prediction and discovering novel therapeutic targets in predetermined clinical cohorts has made substantial use of single-cell omics data. For instance, in 2023, according to the American Cancer Society Inc., a US-based non-profit health group, 1.9 million new cancer cases are expected to be diagnosed in the US in 2021, an increase compared to more than 1.8 million new cancer cases diagnosed in 2020. Therefore, the rising prevalence of cancer is driving the growth of the single-cell omics market.

Product Innovation Marks A Milestone In Single-Cell Omics Market
Product innovation is a key trend gaining popularity in the single-cell omics market. Major companies operating in the single-cell omics market are developing innovative products to sustain their position in the market. For instance, in May 2023, Deepcell, a US-based software provider for single-cell dimensional morphology analysis, launched REM-I Platform, a scalable single-cell imaging, high-dimensional analysis, and cell sorting that provide previously unattainable insights into cell biology. The REM-I Platform will stimulate new ways of discovery in various domains, including cancer biology, developmental biology, stem cell biology, gene therapy, and functional screening, among others, by combining single-cell imaging, sorting, and high-dimensional analysis.

The single-cell omics market covered in this report is segmented -

1) By Product: Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics, Single-Cell Metabolomics
2) By Technology: Cell Isolation Technologies, Sample Preparation Technologies, Analysis Of Next-Generation Sequencing
3) By Application: Oncology, Cell Biology, Neurology, Immunology
4) By End-User: Pharmaceutical And Biotechnology Companies, Academic And Research Organizations, Hospital And Diagnostic Laboratories, Other End Users

Buy Now & Get Exclusive Discount on this Report, Checkout link @
https://www.thebusinessresearchcompany.com/Discount?id=12379&type=discount

Major companies operating in the single-cell omics market report are Danaher Corporation, Merck KGaA, Becton Dickinson and Company, GE HealthCare Technologies Inc., Thermo Fischer Scientific Inc., Agilent Technologies Inc., Sartorius AG, Illumina Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., Qiagen N.V, DiaSorin S.p.A., Tecan Group Ltd., BGI Genomics Co. Ltd., Promega Corporation, 10x Genomics Inc., Takara Bio Inc., NanoString Technologies Inc., Vizgen, HiFiBiO Therapeutics, Deepcell, Immunai, Mission Bio Inc., Standard BioTools Inc., CYTENA GmbH, Celsius Therapeutics, Scailyte AG, Single Cell Discoveries, ImmunoScape Pte. Ltd., Nodexus Inc., 1CellBio Inc.

Contents of the report:
1. Executive Summary
2. Single-Cell Omics Market Report Structure
3. Single-Cell Omics Market Trends And Strategies
4. Single-Cell Omics Market - Macro Economic Scenario
5. Single-Cell Omics Market Size And Growth
…..
27. Single-Cell Omics Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Explore the report store to make a direct purchase of the report @ https://www.thebusinessresearchcompany.com/report/single-cell-omics-global-market-report

Contact us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx

Learn More About The Business Research Company

The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.